News

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Schrödinger announced it will discontinue clinical development of the CDC7 inhibitor SGR-2921 for acute myeloid leukemia (AML) and myelodysplastic syndromes following two patient deaths in an ...